Efficacy and Safety of MG-K10 in Adult Patients with Moderate-to-Severe Uncontrolled Asthma: Results From The Phase 2 Study.pdf
Learn moreEfficacy and Safety of MG-K10 in Adult Patients with Moderate-to Severe Uncontrolled Asthma: Results From The Phase 2 Study.pdf
Learn moreMG-K10 significantly improved clinical signs across all anatomical regions inadults with moderate-to-severe atopic dermatitis.pdf
Learn moreEnhanced powder dispersion of dual-excipient spray-dried powder for mulations of a monoclonal antibody and its fragment for local treatment of severe asthma.pdf
Learn moreEfficacy and Safety of MG-K10 in Adult Patients with Moderate-to-SevereAtopic Dermatitis: Results From The Phase 2 Study.pdf
Learn moreSpray‑Dried and Spray‑Freeze‑Dried Powder Formulations of an Anti‑Interleukin‑4Rα Antibody for Pulmonary Delivery.pdf
Learn moreAll Rights Reserved by HUNAN MABGEEK BIOTECH CO., LTD © 2018-2024 mabge.com